ECMO桥接肺移植患者的分层风险分析:STABLE风险评分
本研究基于UNOS数据库中2004至2018年间630例因ECMO桥接肺移植的成人患者,构建了STABLE评分以预测移植后院内死亡。该评分由6个移植前受者变量组成,总分24分,每增加1分院内死亡风险增加22.0%(95%CI 1.14-1.29,P<.001)。内部交叉验证AUC为86.2%,外部验证AUC为89%。
要点
- STABLE评分用于ECMO桥接肺移植患者的移植后院内死亡风险分层。
- 评分由6个移植前受者变量构成,总分24分,每分增加22.0%死亡风险。
- 内部交叉验证AUC为86.2%,外部验证AUC为89%。
核心结论
- STABLE评分是经内部交叉验证的新工具,可用于ECMO桥接肺移植患者的风险分层,其预测能力可能辅助临床决策并改善移植后结局。
研究设计与样本
- 回顾性队列研究,从UNOS数据库2004至2018年间822例ECMO桥接肺移植患者中排除年龄<18岁、既往移植或2004年前治疗者后纳入630例进行分析。
主要发现
- STABLE评分在UNOS数据库中范围为0至21分,每增加1分院内死亡风险增加22.0%(95%CI 1.14-1.29,P<.001)。
- K折交叉验证的受试者工作特征曲线下面积为86.2%。
- 使用本机构数据库进行外部验证的曲线下面积为89%。
关键数值与推荐
- STABLE评分由6个移植前受者变量构成,总分24分。
- 评分每增加1分,院内死亡比值比增加22.0%(95%CI 1.14-1.29,P<.001)。
临床怎么用
- 可利用STABLE评分对ECMO桥接肺移植患者进行移植后院内死亡风险评估,辅助临床决策。
- 已开发iOS应用以辅助临床使用该评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No clinically validated tool exists to predict in-hospital mortality in patients requiring extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation. We generated a quantitative risk assessment tool for these patients. METHODS: Of 822 patients in the United Network for Organ Sharing (UNOS) database who required ECMO as bridge to lung transplant between 2004 and 2018, 630 were included in the analysis after exclusion for age <18 years, prior transplant, or treatment before 2004. Recipient-specific variables associated with posttransplant in-hospital mortality were incorporated into a multivariable logistic regression model in an automated stepwise fashion. Linear prediction was used to construct the Recipient Stratification Risk Analysis in Bridging Patients to Lung Transplant on ECMO (STABLE) score. K-fold cross-validation provided an unbiased estimate of out-of-sample performance. After further exclusion for University of Pennsylvania patients, the remaining cohort was used for external score validation. An iOS application was developed to aid clinical use. RESULTS: Six recipient-specific, pretransplant variables were translated into a 24-point score. STABLE scores in the United Network for Organ Sharing (UNOS) database ranged from 0 to 21, and each point increased the odds of in-hospital mortality by 22.0% (95% confidence interval, 1.14-1.29, P < .001). K-fold cross-validation yielded a receiver operating characteristic area under the curve of 86.2%. Validation of the STABLE score using our institutional database yielded an area under the curve of 89%. CONCLUSIONS: The STABLE score is a novel, internally cross-validated tool for risk stratification of patients on ECMO as a bridge to transplant. Its predictive power and accuracy may aid clinical decision-making and improve posttransplant outcomes.
引用
- Habertheuer A, Richards T, Sertic F, et al. Stratification Risk Analysis in Bridging Patients to Lung Transplant on ECMO: The STABLE Risk Score. Ann Thorac Surg. 2020. PMID: 32360877. doi:10.1016/j.athoracsur.2020.03.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。